{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Gastrointestinal+Tract&page=8", "query": { "condition": "Gastrointestinal Tract", "page": 8 }, "page_size": 10 }, "pagination": { "page": 8, "page_size": 10, "total_count": 3569, "total_pages": 357, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Gastrointestinal+Tract&page=9&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Gastrointestinal+Tract&page=7&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-15T10:36:41.713Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05451849", "title": "A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Mesothelioma", "Mesotheliomas Pleural", "Mesothelioma, Malignant", "Mesothelioma Peritoneum", "Ovarian Cancer", "Ovarian Serous Adenocarcinoma", "Pancreatic Cancer", "Pancreatic Adenocarcinoma", "Colorectal Cancer", "Triple Negative Breast Cancer", "TNBC - Triple-Negative Breast Cancer", "Ovarian Adenocarcinoma", "Pancreatic Neoplasms", "Colorectal Neoplasms", "Ovarian Neoplasms", "Cholangiocarcinoma", "Non Small Cell Lung Cancer" ], "interventions": [ { "name": "TC-510", "type": "BIOLOGICAL" }, { "name": "Fludarabine", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "TCR2 Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 14, "start_date": "2022-06-21", "completion_date": "2025-08-30", "has_results": true, "last_update_posted_date": "2026-07-13", "last_synced_at": "2026-11-15T10:36:41.713Z", "location_count": 7, "location_summary": "San Franciso, California • Miami, Florida • Bethesda, Maryland + 4 more", "locations": [ { "city": "San Franciso", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Bethesda", "state": "Maryland" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "The Bronx", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05451849" }, { "nct_id": "NCT03039335", "title": "The Impact of Delayed Diagnosis of Alpha-1 Antitrypsin Deficiency", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Alpha 1-Antitrypsin Deficiency" ], "interventions": [], "intervention_types": [], "sponsor": "Biocerna LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 43, "start_date": "2016-12-15", "completion_date": "2018-04-15", "has_results": false, "last_update_posted_date": "2018-07-16", "last_synced_at": "2026-11-15T10:36:41.713Z", "location_count": 1, "location_summary": "Fulton, Maryland", "locations": [ { "city": "Fulton", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03039335" }, { "nct_id": "NCT02498535", "title": "Efficacy and Safety of Inhaled Nitric Oxide (NO) in Cystic Fibrosis (CF) Patients", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cystic Fibrosis" ], "interventions": [ { "name": "Nitric Oxide 160 ppm", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novoteris, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 49, "start_date": "2017-02-22", "completion_date": "2020-06-01", "has_results": false, "last_update_posted_date": "2021-03-05", "last_synced_at": "2026-11-15T10:36:41.713Z", "location_count": 6, "location_summary": "Garden Grove, California • Los Angeles, California • Columbus, Ohio + 3 more", "locations": [ { "city": "Garden Grove", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Columbus", "state": "Ohio" }, { "city": "Charleston", "state": "South Carolina" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT02498535" }, { "nct_id": "NCT06154447", "title": "Evaluation of VX-828 in Healthy Participants and in Participants With Cystic Fibrosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Cystic Fibrosis" ], "interventions": [ { "name": "VX-828", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Itraconazole", "type": "DRUG" }, { "name": "Midazolam", "type": "DRUG" }, { "name": "Tezacaftor", "type": "DRUG" }, { "name": "VX-118", "type": "DRUG" }, { "name": "Deutivacaftor", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Vertex Pharmaceuticals Incorporated", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 165, "start_date": "2023-12-12", "completion_date": "2026-07-10", "has_results": false, "last_update_posted_date": "2026-08-10", "last_synced_at": "2026-11-15T10:36:41.713Z", "location_count": 12, "location_summary": "Hollywood, Florida • Orlando, Florida • Overland Park, Kansas + 9 more", "locations": [ { "city": "Hollywood", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Overland Park", "state": "Kansas" }, { "city": "Lexington", "state": "Kentucky" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT06154447" }, { "nct_id": "NCT03536247", "title": "Papillary Balloon Dilation Versus Intraductal Lithotripsy", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Choledocholithiasis" ], "interventions": [ { "name": "Initial therapy with papillary balloon dilation", "type": "PROCEDURE" }, { "name": "Initial therapy with intraductal lithotripsy", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "University of Southern California", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "115 Years", "sex": "ALL", "summary": "18 Years to 115 Years" }, "enrollment_count": 90, "start_date": "2018-09-07", "completion_date": "2024-12", "has_results": false, "last_update_posted_date": "2022-06-15", "last_synced_at": "2026-11-15T10:36:41.713Z", "location_count": 2, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03536247" }, { "nct_id": "NCT01065818", "title": "Early Prediction of Pathology Response of Chemoradiotherapy With FLT PET", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Esophageal Cancer", "Non-small Cell Lung Cancer" ], "interventions": [ { "name": "Fluoro-L-Thymidine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Columbia University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 6, "start_date": "2009-08", "completion_date": "2013-02", "has_results": true, "last_update_posted_date": "2017-09-26", "last_synced_at": "2026-11-15T10:36:41.713Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01065818" }, { "nct_id": "NCT06805825", "title": "A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Gastrointestinal Stromal Tumors", "Small-cell Lung Cancer", "Adenoid Cystic Carcinoma", "Uveal Melanoma", "Neuroendocrine Tumors", "Chromophobe Renal Cell Carcinoma", "Clear Cell Renal Cell Carcinoma" ], "interventions": [ { "name": "NN3201", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novelty Nobility, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 67, "start_date": "2025-02-03", "completion_date": "2027-12-31", "has_results": false, "last_update_posted_date": "2026-11-13", "last_synced_at": "2026-11-15T10:36:41.713Z", "location_count": 5, "location_summary": "Ann Arbor, Michigan • Cleveland, Ohio • Portland, Oregon + 2 more", "locations": [ { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Cleveland", "state": "Ohio" }, { "city": "Portland", "state": "Oregon" }, { "city": "Houston", "state": "Texas" }, { "city": "Fairfax", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT06805825" }, { "nct_id": "NCT03542240", "title": "Effects of Curcumin Supplementation on Gut Barrier Function in Patients With Metabolic Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Obesity", "High Blood Pressure", "High Cholesterol", "Type2 Diabetes", "Heart Diseases" ], "interventions": [ { "name": "Curcumin", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Virginia Commonwealth University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 15, "start_date": "2018-09-19", "completion_date": "2020-11-13", "has_results": false, "last_update_posted_date": "2021-01-26", "last_synced_at": "2026-11-15T10:36:41.713Z", "location_count": 1, "location_summary": "Richmond, Virginia", "locations": [ { "city": "Richmond", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03542240" }, { "nct_id": "NCT05273268", "title": "ZOE METHOD Study: Comparing Personalized vs. Generalized Nutrition Guidelines", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Personalized Nutrition" ], "interventions": [ { "name": "Personalized nutrition", "type": "OTHER" }, { "name": "Generalized nutrition", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Zoe Global Limited", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "40 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "40 Years to 70 Years" }, "enrollment_count": 347, "start_date": "2022-04-04", "completion_date": "2023-09-08", "has_results": false, "last_update_posted_date": "2025-09-08", "last_synced_at": "2026-11-15T10:36:41.713Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05273268" }, { "nct_id": "NCT00739453", "title": "A Phase 1 Dose-escalation Study of OSI-906 and Erlotinib (Tarceva®)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Advanced Solid Tumors" ], "interventions": [ { "name": "OSI-906", "type": "DRUG" }, { "name": "erlotinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Astellas Pharma Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 95, "start_date": "2008-10-23", "completion_date": "2012-03-03", "has_results": false, "last_update_posted_date": "2024-11-20", "last_synced_at": "2026-11-15T10:36:41.713Z", "location_count": 3, "location_summary": "Aurora, Colorado • Baltimore, Maryland • Detroit, Michigan", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT00739453" } ] }